LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.14 | 84.90 | 3390 | 3682 | 0.9207 | 0.9698 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.14 | 84.90 | 3440 | 3682 | 0.9343 | 0.9752 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.84 | 84.90 | 277 | 4003 | 0.0692 | 0.2370 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.84 | 84.90 | 3800 | 4003 | 0.9493 | 0.9814 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.84 | 84.90 | 3640 | 4003 | 0.9093 | 0.9661 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.84 | 84.90 | 3699 | 4003 | 0.9240 | 0.9718 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.55 | 84.90 | 288 | 4287 | 0.0672 | 0.2410 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.55 | 84.90 | 4010 | 4287 | 0.9352 | 0.9765 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.55 | 84.90 | 3862 | 4287 | 0.9007 | 0.9634 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.55 | 84.90 | 3912 | 4287 | 0.9123 | 0.9678 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.25 | 84.90 | 334 | 4539 | 0.0736 | 0.2695 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.25 | 84.90 | 4374 | 4539 | 0.9635 | 0.9871 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.25 | 84.90 | 4093 | 4539 | 0.9016 | 0.9642 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.25 | 84.90 | 4139 | 4539 | 0.9117 | 0.9681 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.95 | 84.90 | 350 | 4952 | 0.0707 | 0.2731 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.95 | 84.90 | 4722 | 4952 | 0.9535 | 0.9838 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.95 | 84.90 | 4373 | 4952 | 0.8830 | 0.9580 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.95 | 84.90 | 4434 | 4952 | 0.8953 | 0.9627 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 48.65 | 84.90 | 394 | 5328 | 0.0739 | 0.2931 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 48.65 | 84.90 | 5033 | 5328 | 0.9445 | 0.9810 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 48.65 | 84.90 | 4674 | 5328 | 0.8771 | 0.9566 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 48.65 | 84.90 | 4723 | 5328 | 0.8863 | 0.9600 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.36 | 84.90 | 450 | 5651 | 0.0796 | 0.3170 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.36 | 84.90 | 5271 | 5651 | 0.9327 | 0.9771 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.36 | 84.90 | 4997 | 5651 | 0.8843 | 0.9598 | MN20160318_Q02 | N08 |